Nektar Therapeutics Overview
Nektar Therapeutics Target Price
Where could NKTR trade next? Consensus target price: $100.
Get informed when a big investor buys or sells
+ FollowShare Price
$60.4
Average Target Price
$101.50
68% upside
68% upside2 analysts in the last 4 months
High: $153 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-23 | Wedbush | $50 |  17.2% downside |  |
| 2026-07-22 | Canaccord GenuityEdward Nash | $153 | 153.3% upside | |
| 2026-05-11 | WedbushMartin Fan | $80 | 32.5% upside | |
| 2026-05-08 | Piper SandlerYasmeen Rahimi | $192 | 217.9% upside | |
| 2026-04-21 | Wedbush | $95 | 57.3% upside | |
| 2026-04-20 | H.C. Wainwright | $185 | 206.3% upside | |
| 2026-03-13 | OppenheimerJay Olson | $140 | 131.8% upside | |
| 2026-02-10 | BTIG | $151 | 150% upside | |
| 2026-02-10 | H.C. Wainwright | $165 | 173.2% upside | |
| 2026-01-26 | Piper SandlerYasmeen Rahimi | $105 | 73.8% upside | |
| 2025-12-16 | H.C. Wainwright | $135 | 123.5% upside | |
| 2025-12-16 | OppenheimerJay Olson | $115 | 90.4% upside | |
| 2025-11-24 | JefferiesRoger Song | $121 | 100.3% upside | |
| 2025-09-18 | JefferiesRoger Song | $99 | 63.9% upside | |
| 2022-04-18 | Mizuho SecuritiesMara Goldstein | $6 | 90.1% downside | |
| 2022-03-01 | J.P. MorganJessica Fye | $17 | 71.9% downside | |
| 2021-11-08 | Ladenburg Thalmann & Co.Aydin Huseynov | $20 | 66.9% downside | |
| 2021-05-18 | Goldman SachsChris Shibutani | $24 | 60.3% downside | |